These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Current approaches to the diagnosis and treatment of systemic mastocytosis. Bains SN; Hsieh FH Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640 [TBL] [Abstract][Full Text] [Related]
13. Interest of interferon alpha in systemic mastocytosis. The French experience and review of the literature. Simon J; Lortholary O; Caillat-Vigneron N; Raphaël M; Martin A; Brière J; Barète S; Hermine O; Casassus P; Pathol Biol (Paris); 2004 Jun; 52(5):294-9. PubMed ID: 15217717 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis]. Sotlar K Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612 [TBL] [Abstract][Full Text] [Related]
15. Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review. Stoecker MM; Wang E Arch Pathol Lab Med; 2012 Jul; 136(7):832-8. PubMed ID: 22742558 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. Valent P; Sperr WR; Schwartz LB; Horny HP J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337 [TBL] [Abstract][Full Text] [Related]
17. [Mastocytosis, classification, biological diagnosis and therapy]. Arock M Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424 [TBL] [Abstract][Full Text] [Related]
18. Indolent systemic mastocytosis: a case and review of the current available treatment options. Lee Y; Wood P; Soyer HP Dermatol Online J; 2013 Jun; 19(6):18562. PubMed ID: 24011312 [TBL] [Abstract][Full Text] [Related]